Presbyterian Healthcare Services (PHS) and GW RhythmX today announced the expansion of the RhythmX AI Precision Care Platform to be used by PHS' 200 primary care clinicians. The expansion is part of ...

Over the last 20 years, scientific and technological advances have created more sophisticated precision medicine solutions that deliver better and more personalized care to patients. This approach has ...

M42 was built for this moment. Created as a global health organization powered by AI, technology and genomics, M42 was designed to operate across the full health continuum: global patient care ...

Get Well and RhythmX AI, two companies in the SymphonyAI portfolio, announced this week that they plan to merge, bringing their respectve patient engagement and precision medicine to a new combine ...

The US Oncology Network comprises over 3200 health care providers and 700 sites of service, with more than 70% of physicians participating in the Enhancing Oncology Model. Precision Care Companion, ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

According to Joshua Resnikoff, founder of Sunstone Health, healthcare costs tied to genetic and rare conditions represent one of the most persistent liabilities for employers operating self-funded ...

As a neonatology trainee Adrianne Bischoff, a University of Iowa clinical assistant professor of pediatrics in neonatology, encountered numerous sick infants at a hospital who required precision care ...

LONDON, July 26, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that its venture capital arm, Hikma Ventures, has invested in Octave ...

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast cancer care and payer friction. While the scientific frontier of the oncology ...